Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
07:58
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

51st ERA-EDTA CONGRESS

 

31 May - 3 June 2014 AMSTERDAM
FAQs
   
Discussion forum - 51st ERA-EDTA CONGRESS
    Topic - H) Clinical Nephrology, Chronic Kidney Disease (CKD). H5) Pathophysiology and clinical studies in CKD 1-5.

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 267
Visits: 19
Title: PREDICTORS OF HYPERKALEMIA RISK FOLLOWING HYPERTENSION CONTROL WITH ALDOSTERONE BLOCKADE ACCORDING TO THE PRESENCE OR ABSENCE OF CHRONIC KIDNEY DISEASE
Authors: Ye Na Kim ,
Centre: Kosin University College of Medicine

You must be registered to reply or comment.

PREDICTORS OF HYPERKALEMIA RISK FOLLOWING HYPERTENSION CONTROL WITH ALDOSTERONE BLOCKADE ACCORDING TO THE PRESENCE OR ABSENCE OF CHRONIC KIDNEY DISEASE

Ye Na Kim
Thread initiator
Subspeciality
Reg: 5/3/2014 4:05:00 AM
Comment# 1
Spironolactone was well tolerated in selected CKD patients. The risks of serious hyperkalemia or significant reduction of eGFR appear to be low. Strict monitoring over the first month of treatment followed by standard surveillance for angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers is suggested.

Comment added on 5/3/2014 4:09:00 AM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 7
Visits: 477
Title: SEVERE SYMPTOMATIC ACUTE HYPONATREMIA IN TRAUMATIC BRAIN INJURY RESPONDS VERY RAPIDLY SINGLE 15 MG DOSE OF TOLVAPTAN: A MAYO CLINIC HEALTH SYSTEM HOSPITAL EXPERIENCE - NEED FOR CAUTION WITH TOLVAPTAN IN YOUNGER PATIENTS WITH PRESERVED RENAL FUNCTION
Authors: MACAULAY ONUIGBO ,
Centre: MAYO CLINIC, ROCHESTER & MAYO CLINIC HEALTH SYSTEM, EAU CLAIRE

Poster most viewed in this topic
Poster: 251
Visits: 297
Title: ACID-BASE BALANCE IN PHASE 2 AND PHASE 3 TRIALS OF ZS-9 FOR HYPERKALAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Authors: Bhupinder Singh , Ash, Lavin, Yang, Rasmussen
Centre: Apex Research of Riverside


 








PosterSessionOnline
Logo Draft
 
Logo Cert